Skip to comments.Novartis Blood-Pressure Drug Rasilez (Tekturna) to Carry Warning (serious)
Posted on 02/17/2012 1:51:48 PM PST by Innovative
Aliskiren has been sold under the brand name Rasilez in Europe and Tekturna in the U.S. since 2007.
EMA said it has ruled that aliskiren be "contraindicated," or not prescribed, to diabetic patients or to people with kidney problems who are also taking older hypertension drugs known as ACE inhibitors or angiotensin receptor blockers. Data suggest a risk of adverse outcomes in such patients, including hypotension, stroke and changes in renal function, including acute renal failure, the EMA said.
Novartis wrote to physicians world-wide then recommending that patients with Type 2 diabetes shouldn't be treated with aliskiren, or combination products containing aliskiren, if they are also receiving an ACE inhibitor or ARB.
(Excerpt) Read more at online.wsj.com ...
if Liberals hadn’t made such a mess of things we’d have far fewer people needing blood pressure meds.